Trials / Conditions / Neoplasm Recurrence, Local

Neoplasm Recurrence, Local

21 registered clinical trials studyying Neoplasm Recurrence, Local — 5 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Non-inferiority Study Comparing Salvage Pelvic Radiotherapy in 25 Fractions (62.5 Gy/25) Versus 20 Fractions ( NCT07483658	CHU de Quebec-Universite Laval	N/A
Recruiting	Dose Finding Study of Zanzalintinib With Pembrolizumab and Cetuximab in Head and Neck SCC NCT06912087	University of Chicago	Phase 1
Recruiting	Iparomlimab and Tuvonralimab With Chemoradiation for the Treatment of Locally Recurrent and Oligometastatic Ce NCT06942416	Shandong Cancer Hospital and Institute	Phase 2
Recruiting	Cadonilimab With Chemoradiation for Recurrent and Oligometastatic Endometrial Carcinoma NCT06532539	Shandong Cancer Hospital and Institute	Phase 2
Recruiting	Multicenter Clinical Trial on the Effectiveness and Safety of Instillation of BCG and Alternative BCG Protocol NCT06441110	Fujian Medical University Union Hospital	Phase 3
Completed	Randomized Trial of Accelerated Partial Breast Irradiation NCT03583619	Cancer Institute and Hospital, Chinese Academy of Medical Sciences	N/A
Active Not Recruiting	Accelerated Partial Breast Irradiation With IMRT in Early Breast Cancer NCT03583580	Cancer Institute and Hospital, Chinese Academy of Medical Sciences	N/A
Completed	Epidural Anesthesia-analgesia and Long-term Survival After Lung Cancer Surgery NCT02801409	Peking University First Hospital	N/A
Completed	Incidence, Risk Factor, Treatment and Overall Survival of Locally Recurrent Rectal Cancer NCT05475301	Radboud University Medical Center	—
Completed	Incidence, Risk Factor, Treatment and Overall Survival of Locoregionally Recurrent Colon Cancer NCT05475288	Radboud University Medical Center	—
Completed	Fractionated Radiosurgery for Painful Spinal Metastases NCT01594892	Wuerzburg University Hospital	N/A
Completed	Prospective Phase II Study of Intraoperative Radiotherapy (IORT) in Elderly Patients with Small Breast Cancer NCT01299987	Universitätsmedizin Mannheim	N/A
Completed	Screening MRI for Cancer Recurrence in Patients Treated With Breast Conserving Therapy NCT01257152	Seoul National University Hospital	—
Terminated	Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomyci NCT01200992	Bioniche Life Sciences Inc.	Phase 3
Unknown	Safety and Efficacy Study of Cylindrical Abdominoperineal Resection to Treat Rectal Cancer NCT00949273	Beijing Chao Yang Hospital	—
Terminated	Chemotherapy or Not, Following Complete Treatment of Hepatic Cancer in Cirrhotic Patients NCT00470340	Assistance Publique - Hôpitaux de Paris	Phase 3
Completed	Phase 3 Trial of Litx™ Plus Chemotherapy vs. Chemotherapy Only Treating Colorectal Cancer Patients With Recurr NCT00440310	Light Sciences Oncology	Phase 3
Withdrawn	Gene Therapy for Prostate Cancer That Returns After Radiation Therapy NCT00110526	Simon Hall	Phase 1
Completed	A Study to Evaluate Bevacizumab and Chemotherapy or Tarceva in Treating Recurrent or Refractory NSCLC (Non-Sma NCT00095225	Genentech, Inc.	Phase 2
Unknown	Rhenium Re 188 P2045 in Patients With Lung Cancer Who Have Received or Refused to Receive Prior Chemotherapy NCT00100256	Andarix Pharmaceuticals	Phase 1 / Phase 2
Completed	Taxotere (Docetaxel) in 1st Line Treatment of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma NCT00401323	Sanofi	Phase 2 / Phase 3